The Health Wildcatters accelerator in Dallas says its second class of startups have raised $4.5 million since leaving the program in November.
Silicone Arts Laboratories, which makes a synthetic skin product, received the most of the companies, closing on a $1.5 million Series A round last month. Tennessee-based Innova was the lead investor and Green Park & Golf Ventures in Dallas also participated.
Other companies in the class that raised funds included Lantern Pharma, which is developing a drug candidate for ovarian and prostate cancers, with $960,000 from Green Park & Golf; and Orb Health, which raised $650,000.
Lucy Soderberg, a spokeswoman for the accelerator, says that the inaugural cohort of Health Wildcatters companies raised slightly more, $4.6 million.
Health Wildcatters will host its third class of healthcare-related startups this fall in the 12-week accelerator program.